Phase Ib study of gevokizumab (GEVO) in combination with standard-of-care (SoC) anticancer therapies in patients (pts) with metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer ...
A protein-based blood panel test for the early detection of colorectal cancer and advanced neoplasia. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
Accurate measurement of colorectal polyp size is crucial for determining the appropriate surveillance intervals and assessing the risk of malignant progression. Various techniques have been ...
Colorectal polyps are abnormal growths in the colon that can lead to colorectal cancer if not detected and removed early. The detection and segmentation of these polyps during colonoscopy are ...
Malignancy Transformation Probability: Develop a risk model to estimate the likelihood of polyps transitioning from benign to malignant states using baseline characteristics and patient demographics.